CompletedNot Applicable

Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face Recognition

China1,500 participantsStarted 2024-06-01

Plain-language summary

Collect facial images and voice and audio of patients with rhinitis in the department of otolaryngology, and collect the examination results of patients with rhinitis who have received electronic fiber nasopharyngoscopy. Skin prick test to a standard panel of aeroallergens or by using the ImmunoCAP Phadiatop test for detecting immunoglobulin E antibodies against various common inhalant allergenswere detected, and a prediction model for the type of rhinitis was finally established.

Who can participate

Age range8 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects understood the purpose and procedure of the trial and signed an informed consent form, and voluntarily participated in this study;
✓. Subjects were initially clinically diagnosed with chronic rhinitis;
✓. Subjects were aged 8-80 years old, limited to Chinese nationality, and were able to perform basic examinations and cooperate with face photography and voice collection.

Exclusion criteria

✕. Those who received systemic immunotherapy, used systemic or local glucocorticoids as well as leukotriene receptor antagonists within one month;
✕. Those who suffer from immune system diseases, autoimmune diseases, allergic diseases or allergies and have a history of food allergy;
✕. Other serious systemic diseases, such as active tuberculosis, rheumatic heart disease, congenital heart disease, arthritis, nephritis, hypertension, psychosis, dermatitis, epilepsy and so on;
✕. Women during lactation and pregnancy;
✕. History of upper respiratory tract infection or more serious infectious diseases within three months;
✕. Those who are currently participating in another clinical study or have participated in another clinical study within 90 days;
✕. Other patients who, in the judgment of the clinician, are not suitable for inclusion in the study.

What they're measuring

Allergen Test Results

Timeframe: 30 minutes

Trial details

NCT IDNCT06474923

SponsorZheng Liu

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Body Image trials